Sign in

CIK 0001682639 · Non-accelerated filer<br>Smaller reporting company

HYPERION DEFI, INC.

Sign in to watch
Ticker
HYPD
Exchange
Nasdaq
Industry
Finance Services
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
471178401
Phone
833-393-6684
Business address
3090 NOWITZKI WAY, SUITE 300, DALLAS, TX, 75219
Former names
EYENOVIA, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 5 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-09-11 MARIO ERNEST Director Grant or award +7,288 334,527
2020-09-11 MARIO ERNEST Director Grant or award · Stock Option (right to buy) +9,820 9,820
2020-09-11 LaBelle Curt H Director Grant or award +7,288 35,273
2020-09-11 LaBelle Curt H Director Grant or award · Stock Option (right to buy) +9,820 9,820
2020-09-11 LEE KENNETH B JR Director Grant or award +7,288 19,359
2020-09-11 LEE KENNETH B JR Director Grant or award · Stock Option (right to buy) +9,820 9,820
2020-09-11 SUN ANTHONY Y Director Grant or award +7,288 19,359
2020-09-11 SUN ANTHONY Y Director Grant or award · Stock Option (right to buy) +9,820 9,820
2020-09-11 MATHER CHARLES E IV Director Grant or award +7,288 23,359
2020-09-11 MATHER CHARLES E IV Director Grant or award · Stock Option (right to buy) +9,820 9,820
2020-09-11 ESHELMAN FREDRIC N Director Grant or award +7,288 1,292,787
2020-09-11 ESHELMAN FREDRIC N Director Grant or award · Stock Option (right to buy) +9,820 9,820
2020-08-20 Grant Stuart M. 10% owner Purchase +451,620 $2.06 $929K 4,044,748
2020-08-20 Grant Stuart M. 10% owner Option exercise · Class A Warrant −903,240 0
2020-08-19 Grant Stuart M. 10% owner Purchase +333,000 $3.60 $1.2M 3,593,128
2020-06-30 Rowe Michael M Vice President, Commercial Grant or award · Stock Option (right to buy) +141,622 141,622
2020-06-30 Ianchulev Tsontcho Chief Executive Officer Grant or award · Stock Option (right to buy) +285,255 285,255
2020-06-30 GANDOLFO JOHN P Chief Financial Officer Grant or award · Stock Option (right to buy) +114,774 114,774
2020-06-30 Clauson Luke VP, R&D and Manufacturing Grant or award · Stock Option (right to buy) +101,358 101,358
2020-06-30 Clasby Jennifer G VP, Clinical Operations Grant or award · Stock Option (right to buy) +121,410 121,410

Page 12 of 16 · 317 trades